Historical record - last NADAC effective date: 8/21/2024

Product Information

MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3420 per GM under NDC 68462022517. Its NADAC has been published 562 times since Nov 28, 2013.

FDA first approved this application on May 28, 2008.

MOMETASONE FUROATE 0.1% OINT

Mometasone furoate
$0.3420per GM

Strength

1 mg/g

NDC

68462022517

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

8/21/2024

Active Ingredients

MOMETASONE FUROATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078571

FDA Approved

5/28/2008

On Market Since

5/28/2008

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 562 times since Nov 28, 2013, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3420 per GM
All-time high$0.6681 (Feb 12, 2014)
All-time low$0.2383 (Jan 22, 2020)
Median price$0.3362
Average price$0.3669
Largest weekly change+49.7% (Jan 22, 2014)
Weeks tracked562
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-17.0%

5Y

+3.1%

All

-17.5%

Last surveyed Aug 28, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 35%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3420 per GM (NDC 68462022517), effective Aug 28, 2024.

How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 17.5%. It has been tracked across 562 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?

Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.2383 (Jan 22, 2020) to a high of $0.6681 (Feb 12, 2014), with a median of $0.3362 per GM.

Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% OINT, is $0.2236 per GM — about 35% below MOMETASONE FUROATE 0.1% OINT.

Who manufactures MOMETASONE FUROATE 0.1% OINT?

MOMETASONE FUROATE 0.1% OINT (NDC 68462022517) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.